Skip to main content

Advertisement

Log in

Abstract

Background

Intravitreal injections are the fastest growing cause of endophthalmitis and can result in severe vision loss. The prevention, diagnosis and management of such infections remain unclear and at times controversial.

Methods

We searched Pubmed for keywords "prophylaxis," "endophthalmitis," "intravitreal injection." We focused on studies published in the last 2 years as well as other recent studies with particular attention to data on the incidence, microbiology, prevention, and treatment of injection-related endophthalmitis.

Results

Over 20 relevant studies were found. With povidone–iodine preparation, the per–injection endophthalmitis rate is low at about 0.03%. Antibiotics do not appear to be beneficial for prevention of post–injection endophthalmitis. The best timing of vitrectomy is unclear.

Conclusions

Antibiotic prophylaxis is probably not needed when giving intravitreal injections. More data is needed to help determine the proper treatment for post-injection endophthalmitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Lanzetta P, Mitchell P, Wolf S, Veritti D (2013) Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol 97:1497–1507

    Article  PubMed  Google Scholar 

  2. Brechner RJ, Rosenfeld PJ, Babish JD, Caplan S (2011) Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100% 2008 medicare fee-for-service part B claims file. Am J Ophthalmol 151:887–895

    Article  PubMed  Google Scholar 

  3. Durand ML (2013) Endophthalmitis. Clin Microbiol Infect 19:227–234

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Englander M, Chen TC, Paschalis EI, Miller JW, Kim IK (2013) Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates. Br J Ophthalmol 97:460–465

    Article  PubMed  Google Scholar 

  5. Lyall DA, Tey A, Foot B et al (2012) Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes. Eye (Lond) 26:1517–1526

    Article  CAS  Google Scholar 

  6. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr et al (2011) Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 31:662–668

    Article  CAS  PubMed  Google Scholar 

  7. McCannel CA (2011) Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 31:654–661

    CAS  PubMed  Google Scholar 

  8. Simunovic MP, Rush RB, Hunyor AP, Chang AA (2012) Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 96:862–866

    Article  PubMed  Google Scholar 

  9. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ (2008) Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. J Ocul Pharmacol Ther 24:1–7

    Article  CAS  PubMed  Google Scholar 

  10. Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M (2013) Minimizing the endophthalmitis rate following intravitreal injections using 0.25 % povidone–iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol 251:1885–1890

    Article  CAS  PubMed  Google Scholar 

  11. Moss JM, Sanislo SR, Ta CN (2009) A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 116:1498–1501

    Article  PubMed  Google Scholar 

  12. Bhavsar AR, Googe JM Jr, Stockdale CR et al (2009) Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser–ranibizumab–triamcinolone clinical trials. Arch Ophthalmol 127:1581–1583

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR (2012) Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 130:809–810

    Article  PubMed Central  PubMed  Google Scholar 

  14. Bhatt SS, Stepien KE, Joshi K (2011) Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 31:2032–2036

    Article  CAS  PubMed  Google Scholar 

  15. Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC (2012) Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 119:1609–1614

    Article  PubMed  Google Scholar 

  16. Storey P, Dollin M, Pitcher J et al (2014) The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Ophthalmology 121:283–289

    Article  PubMed  Google Scholar 

  17. Yin VT, Weisbrod DJ, Eng KT et al (2013) Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 131:456–461

    Article  CAS  PubMed  Google Scholar 

  18. Kim SJ, Toma HS (2011) Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol 129:1180–1188

    Article  PubMed  Google Scholar 

  19. Dave SB, Toma HS, Kim SJ (2013) Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology 120:937–941

    Article  PubMed  Google Scholar 

  20. Friedman DA, Mason JO 3rd, Emond T, McGwin G Jr (2013) Povidone–iodine contact time and lid speculum use during intravitreal injection. Retina 33:975–981

    Article  CAS  PubMed  Google Scholar 

  21. Doshi RR, Leng T, Fung AE (2012) Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 32:473–476

    PubMed  Google Scholar 

  22. Goldberg RA, Flynn HW Jr, Miller D, Gonzalez S, Isom RF (2013) Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results. Ophthalmology 120:1448–1453

    Article  PubMed  Google Scholar 

  23. Sheyman AT, Cohen BZ, Friedman AH, Ackert JM (2013) An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. JAMA Ophthalmol 131:864–869

    Article  CAS  PubMed  Google Scholar 

  24. Palmer JM, Amoaku WM, Kamali F (2013) Quality of bevacizumab compounded for intravitreal administration. Eye (Lond) 27:1090–1097

    Article  CAS  Google Scholar 

  25. Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF (2011) Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci 52:1023–1034

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA (2013) Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection. Retina 33:1407–1416

    Article  CAS  PubMed  Google Scholar 

  27. Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H (2012) Endophthalmitis following intravitreal injections. Graefes Arch Clin Exp Ophthalmol 250:499–505

    Article  CAS  PubMed  Google Scholar 

  28. Nelson ML, Tennant MT, Sivalingam A, Regillo CD, Belmont JB, Martidis A (2003) Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23:686–691

    Article  PubMed  Google Scholar 

  29. Fagan XJ, Al-Qureshi S (2013) Intravitreal injections: a review of the evidence for best practice. Clin Experiment Ophthalmol 41(5):500–507

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christopher N. Ta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, C.Q., Ta, C.N. Prevention and treatment of injection-related endophthalmitis. Graefes Arch Clin Exp Ophthalmol 252, 1027–1031 (2014). https://doi.org/10.1007/s00417-014-2644-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2644-0

Keywords

Navigation